Trautec Medical Technology is a Chinese startup focused on developing synthetic human collagen. The company's core product is synthetic human collagen technology. According to a company statement, Trautec raised 200 million yuan (about $27.3 million) in a Series B financing. The round was led by L Catterton. The article does not name other participating investors or provide details on valuation, use of proceeds, revenue, users, or future plans.

Total raised

$27M

Funding rounds

1

Latest round

Series B

Latest activity

Sep 2023